GFAP Antibodies

Antibodies targeting neuroscience biomarkers for research and assay development. Used in neurological disease diagnostics.

A specialized collection of antibodies targeting key neuroscience biomarkers including Tau, Beta Amyloid, PrP, Alpha Synuclein, and TDP-43. These antibodies are designed for research, diagnostic, and preclinical use in neurodegenerative disease investigation.

Monoclonal antibodies designed to target G-protein coupled receptors for research and diagnostic applications. These antibodies enable detection and characterization of GPCR expression in tissues and cells. Suitable for immunoassays and flow cytometry studies.

Antibodies directed against fibrinogen for coagulation assessment and hemostasis diagnostic applications.

Antibodies directed against plasminogen for fibrinolysis evaluation and thrombolytic research.

Antibodies targeting tPA for fibrinolysis evaluation and thrombolytic therapy research.

Antibodies targeting GRP78 heat shock protein for cellular stress and protein folding research.

Diagnostic assay for detecting IgG anti-ganglioside antibodies using multiple methodologies including ELISA and immunoassays. Supports diagnosis of peripheral nerve disorders and autoimmune conditions.

Antibodies targeting alpha-1 antitrypsin for use in diagnostic assays and research applications related to protease inhibition and lung disease.

Antibodies specific to PAI-1 for fibrinolysis regulation assessment and thrombosis research.

Antibodies directed against alpha-2 macroglobulin for protease inhibition studies and clinical diagnostics.

Peptide protein antibody associated with tumor cells, primarily synthesized by fetal liver. Used for detecting AFP expression in hepatocellular carcinoma and germ cell tumors.